Hememics Biotech just raised a $2M seed round with TEDCO’s help
The Gaithersburg company developed a “lab in a hand” device for blood tests and diagnostics.
Words by: Michaela Althouse / Edited by: Sameer Rao
Read The full Technical.ly article – here.
Full disclosure: This article mentions an investment by TEDCO, a Technical.ly Ecosystem Builder client. That relationship has no impact on this report.
To help build its “lab in a hand” tech, Gaithersburg, Maryland’s Hememics Biotech just raised a $2 million seed round.
Maryland’s TEDCO led the Seed 2 round, though a company statement said that other existing investors and a strategic investor also took part. Hememics, founded in 2007, developed a handheld, multiplexed sensor platform for simultaneously testing antibodies, antigens and more in a blood test. The nine-person company was founded by CEO John Warden, a fintech and drug development alum, and chief scientific officer David Ho, a blood platelets expert.
Warden said the company’s sensor technology is more sensitive than existing point-of-care tools. The company’s early entry into the market, which it’s returning to, was in veterinarian health for livestock, although it also..
Read the full Technical.ly article.
- About the Author
- Latest Posts
BioBuzz is a community led, experience focused, biotech and life sciences media and events company. BioBuzz highlights regional breaking news, industry professionals, jobs, events, and resources for business and career growth. Their weekly newsletter is subscribed to by thousands in the BioHealth Capital Region and Greater Philadelphia as the go-to for industry updates.
